390 related articles for article (PubMed ID: 25556170)
21. Super-Enhancer-Associated Transcription Factors Maintain Transcriptional Regulation in Mature Podocytes.
Yang J; Zhang D; Motojima M; Kume T; Hou Q; Pan Y; Duan A; Zhang M; Jiang S; Hou J; Shi J; Qin Z; Liu Z
J Am Soc Nephrol; 2021 Jun; 32(6):1323-1337. PubMed ID: 33771836
[TBL] [Abstract][Full Text] [Related]
22. Function and Regulation of the Wilms' Tumor Suppressor 1 (WT1) Gene in Fish.
Perner B; Bates TJ; Naumann U; Englert C
Methods Mol Biol; 2016; 1467():119-28. PubMed ID: 27417964
[TBL] [Abstract][Full Text] [Related]
23. Wilms' tumor gene 1: lessons from the interface between kidney development and cancer.
Torban E; Goodyer P
Am J Physiol Renal Physiol; 2024 Jan; 326(1):F3-F19. PubMed ID: 37916284
[TBL] [Abstract][Full Text] [Related]
24. Effects of Denys-Drash syndrome point mutations on the DNA binding activity of the Wilms' tumor suppressor protein WT1.
Borel F; Barilla KC; Hamilton TB; Iskandar M; Romaniuk PJ
Biochemistry; 1996 Sep; 35(37):12070-6. PubMed ID: 8810912
[TBL] [Abstract][Full Text] [Related]
25. PINCH1 is transcriptional regulator in podocytes that interacts with WT1 and represses podocalyxin expression.
Wang D; Li Y; Wu C; Liu Y
PLoS One; 2011 Feb; 6(2):e17048. PubMed ID: 21390327
[TBL] [Abstract][Full Text] [Related]
26. A novel Wilms tumor 1 (WT1) target gene negatively regulates the WNT signaling pathway.
Kim MS; Yoon SK; Bollig F; Kitagaki J; Hur W; Whye NJ; Wu YP; Rivera MN; Park JY; Kim HS; Malik K; Bell DW; Englert C; Perantoni AO; Lee SB
J Biol Chem; 2010 May; 285(19):14585-93. PubMed ID: 20220130
[TBL] [Abstract][Full Text] [Related]
27. Intermediate filament protein nestin is expressed in developing kidney and heart and might be regulated by the Wilms' tumor suppressor Wt1.
Wagner N; Wagner KD; Scholz H; Kirschner KM; Schedl A
Am J Physiol Regul Integr Comp Physiol; 2006 Sep; 291(3):R779-87. PubMed ID: 16614054
[TBL] [Abstract][Full Text] [Related]
28. Mutual antagonism of Wilms' tumor 1 and β-catenin dictates podocyte health and disease.
Zhou L; Li Y; He W; Zhou D; Tan RJ; Nie J; Hou FF; Liu Y
J Am Soc Nephrol; 2015 Mar; 26(3):677-91. PubMed ID: 25071087
[TBL] [Abstract][Full Text] [Related]
29. Podocyte apoptosis in diabetic nephropathy by BASP1 activation of the p53 pathway via WT1.
Zhang Y; Xu C; Ye Q; Tong L; Jiang H; Zhu X; Huang L; Lin W; Fu H; Wang J; Persson PB; Lai EY; Mao J
Acta Physiol (Oxf); 2021 May; 232(1):e13634. PubMed ID: 33615732
[TBL] [Abstract][Full Text] [Related]
30. The complex life of WT1.
Wagner KD; Wagner N; Schedl A
J Cell Sci; 2003 May; 116(Pt 9):1653-8. PubMed ID: 12665546
[TBL] [Abstract][Full Text] [Related]
31. Nephron, Wilms' tumor-1 (WT1), and synaptopodin expression in developing podocytes of mice.
Kato T; Mizuno S
Exp Anim; 2017 Aug; 66(3):183-189. PubMed ID: 28179596
[TBL] [Abstract][Full Text] [Related]
32. Disruption of MAGI2-RapGEF2-Rap1 signaling contributes to podocyte dysfunction in congenital nephrotic syndrome caused by mutations in MAGI2.
Zhu B; Cao A; Li J; Young J; Wong J; Ashraf S; Bierzynska A; Menon MC; Hou S; Sawyers C; Campbell KN; Saleem MA; He JC; Hildebrandt F; D'Agati VD; Peng W; Kaufman L
Kidney Int; 2019 Sep; 96(3):642-655. PubMed ID: 31171376
[TBL] [Abstract][Full Text] [Related]
33. Wilms' tumor suppressor gene WT1: from structure to renal pathophysiologic features.
Mrowka C; Schedl A
J Am Soc Nephrol; 2000 Nov; 11 Suppl 16():S106-15. PubMed ID: 11065340
[TBL] [Abstract][Full Text] [Related]
34. The miR-143/145 cluster induced by TGF-β1 suppresses Wilms' tumor 1 expression in cultured human podocytes.
Tabei A; Sakairi T; Hamatani H; Ohishi Y; Watanabe M; Nakasatomi M; Ikeuchi H; Kaneko Y; Kopp JB; Hiromura K
Am J Physiol Renal Physiol; 2023 Jul; 325(1):F121-F133. PubMed ID: 37167274
[TBL] [Abstract][Full Text] [Related]
35. TGF-beta1 reduces Wilms' tumor suppressor gene expression in podocytes.
Sakairi T; Abe Y; Kopp JB
Nephrol Dial Transplant; 2011 Sep; 26(9):2746-52. PubMed ID: 21378152
[TBL] [Abstract][Full Text] [Related]
36. A novel missense mutation of Wilms' Tumor 1 causes autosomal dominant FSGS.
Hall G; Gbadegesin RA; Lavin P; Wu G; Liu Y; Oh EC; Wang L; Spurney RF; Eckel J; Lindsey T; Homstad A; Malone AF; Phelan PJ; Shaw A; Howell DN; Conlon PJ; Katsanis N; Winn MP
J Am Soc Nephrol; 2015 Apr; 26(4):831-43. PubMed ID: 25145932
[TBL] [Abstract][Full Text] [Related]
37. WT1 is a key regulator of podocyte function: reduced expression levels cause crescentic glomerulonephritis and mesangial sclerosis.
Guo JK; Menke AL; Gubler MC; Clarke AR; Harrison D; Hammes A; Hastie ND; Schedl A
Hum Mol Genet; 2002 Mar; 11(6):651-9. PubMed ID: 11912180
[TBL] [Abstract][Full Text] [Related]
38. Notch signaling, wt1 and foxc2 are key regulators of the podocyte gene regulatory network in Xenopus.
White JT; Zhang B; Cerqueira DM; Tran U; Wessely O
Development; 2010 Jun; 137(11):1863-73. PubMed ID: 20431116
[TBL] [Abstract][Full Text] [Related]
39. The mouse Kreisler (Krml1/MafB) segmentation gene is required for differentiation of glomerular visceral epithelial cells.
Sadl V; Jin F; Yu J; Cui S; Holmyard D; Quaggin S; Barsh G; Cordes S
Dev Biol; 2002 Sep; 249(1):16-29. PubMed ID: 12217315
[TBL] [Abstract][Full Text] [Related]
40. Podocyte-specific expression of Cre recombinase promotes glomerular basement membrane thickening.
Balkawade RS; Chen C; Crowley MR; Crossman DK; Clapp WL; Verlander JW; Marshall CB
Am J Physiol Renal Physiol; 2019 May; 316(5):F1026-F1040. PubMed ID: 30810063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
